In vitro diagnostic kit for detecting CYP2C9 and VKORC1 gene polymorphisms to guide warfarin dosing and reduce adverse drug reactions. Enables pharmacogenomic-based anticoagulation therapy optimization in patients requiring warfarin treatment.
Manufactured by
HymonBio Co., Ltd.
Suzhou, Jiangsu, China
HymonBio Co., Ltd. was established in 2015, with co-founder from the Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang BIOBAY, HymonBio has applied for 36 patents and obtained 16 authorized patents; 11 products have obtained Chinese medical device certificates; 59 products have obtained CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate. The company has won awards such as high-tech enterprises, private technology enterprises in Jiangsu Province, enterprises supported by the Double Innovation Plan of Jiangsu Province, and Suzhou Female Innovation and Entrepreneurship Leading Talent Enterprises. Most recently, HymonBio has completed the first round of financing, which is also the first overseas investment project of PerkinElmer Ventures, a leading company in the IVD industry, in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENERI BIOTECH s.r.o.
Czech Republic · 12 relevant products
Shenzhen Uni-medica Technology Co., Ltd
China · 2 relevant products
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 8 relevant products
37 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 111 closest product alternatives
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of CYP2C9 polymorphisms (*2A, *13, HapB3, c2846A>T) according to CPIC and DPWG guidelines. Enables personalized dosing of warfarin and other CYP2C9-metabolized medications.
Shenzhen Uni-medica Technology Co., Ltd · China
A diagnostic kit for detecting CYP2C19 gene polymorphisms in human samples to guide personalized medication therapy.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Specialized gene detection kit for analyzing CYP2D6 genetic variations to predict drug metabolism and response. This test enables precision medicine by guiding drug selection and dosing for individual patients.
108 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products